ClinicalTrials.gg
Not yet recruitingNCT07755787USG-FRACTHEALUpdated Aug 12, 2026

Ultrasound Assessment of Pediatric Fracture Healing With the PLUS Score

An observational study in Bone Fractures, sponsored by University Hospital Hradec Kralove. Not yet recruiting at 1 site in Czechia. Open to participants aged 0 Years to 14 Years. Per ClinicalTrials.gov, last updated 2026-08-12.

Sponsored by University Hospital Hradec Kralove · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,200
Ages
0 Years to 14 Years
Sex
All
01

Study summary

This observational study investigates whether ultrasound can safely and accurately monitor the healing of bone fractures in children, comparing it to standard X-rays. Currently, children with fractures often require multiple X-rays during their recovery, which exposes them to small amounts of ionizing radiation. Ultrasound, on the other hand, is completely radiation-free.

The study aims to evaluate a specific ultrasound scoring system called the PLUS (Pediatric Long-bone Ultrasound Score) score. The study will include pediatric patients who are being treated conservatively (e.g., with a cast) for a long bone fracture, fractures of the sternum, patella and clavicle. During their regularly scheduled follow-up visits, participants will receive a brief ultrasound scan of the fracture site in addition to their standard clinical and X-ray examinations. The medical decisions regarding the patient's treatment will continue to be based entirely on standard care.

The main goal is to determine if the ultrasound PLUS score strongly correlates with the X-ray findings. If proven accurate, this scoring system could help reduce the need for routine X-rays in the future, thereby minimizing radiation exposure and potentially streamlining outpatient workflow.

Read the detailed description

Routine monitoring of pediatric fracture healing relies heavily on conventional radiography. While effective, it exposes growing children to cumulative ionizing radiation. Point-of-care ultrasound (POCUS) represents a promising, radiation-free, and easily accessible alternative for assessing callus formation and bone bridging. To standardize this ultrasound evaluation, specific scoring systems, such as the PLUS score, have been developed.

This prospective observational cohort study is designed to validate the clinical utility and diagnostic accuracy of the PLUS score in pediatric patients treated conservatively for long bone fractures, fractures of the sternum, patella and clavicle.

Methodology:

Patients presenting at the outpatient clinic with conservatively managed long bone fractures, fractures of the sternum, patella and clavicle will be consecutively enrolled. During their standard scheduled follow-up visits, patients will undergo routine care, including clinical evaluation and conventional radiography, to determine clinical and radiological union (e.g., indication for cast removal). Concurrently, an ultrasound examination will be performed to assess the fracture site and calculate the PLUS score.

The study is purely observational. The ultrasound findings will not alter the standard of care; all clinical decisions regarding treatment and immobilization removal will remain strictly based on standard clinical and radiographic assessments.

Data Collection and Analysis:

Patient demographics, injury details, time spent in the waiting room, radiological findings, and ultrasound PLUS scores will be prospectively recorded into a secure REDCap database provided by Masaryk University.

The primary objective is to evaluate the correlation between the PLUS score and the radiographic/clinical signs of bone union, ultimately determining the optimal cut-off value of the PLUS score that safely predicts sufficient healing. Secondary objectives include assessing the potential impact of ultrasound implementation on outpatient workflow efficiency and time management.

02

Conditions studied

  • Bone Fractures

Browse trials for

Keywords

  • Ultrasound
  • Ultrasonography
  • Point-of-care ultrasound
  • POCUS
  • Pediatrics
  • Long bone
  • PLUS score
  • Pediatric traumatology
  • Radiation-free imaging
03

In context

Fractures, Bone

723 studies on the registry are indexed under Fractures, Bone; 114 are open to participants now.

This study's planned enrollment of 1,200 is above the median of 130 across 239 observational studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

University Hospital Hradec Kralove is the lead sponsor of 49 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pediatric patients aged 0 to 14 years with acute fractures of the clavicle, sternum, patella, or long bones managed conservatively with closed reduction and/or immobilization. Participants are recruited consecutively from the outpatient pediatric trauma clinic during routine follow-up visits. The study uses standard clinical care and radiographic assessment, with an additional observational ultrasound examination scored using the PLUS protocol. Surgical fractures, pathological fractures, metabolic bone disease, severe polytrauma, and non-compliance are excluded.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 0 to 14 years.
  • Acute fracture of a clavicle, sternum, patella, or long bone.
  • Conservative treatment planned or ongoing, including closed reduction and immobilization/casting.
  • Scheduled for routine outpatient follow-up with clinical and radiographic assessment.
  • Written from parent/legal guardian, with child assent when appropriate.

Exclusion criteria

Exclusion Criteria:

  • Fractures treated surgically, including internal or external fixation.
  • Pathological fractures.
  • Metabolic bone disease or known bone fragility disorder.
  • Severe polytrauma or unstable clinical condition.
  • Inability to complete follow-up or non-compliance with study procedures.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,200 participants (estimated)
Patient registry
No

Groups and cohorts

  • Conservatively treated pediatric fractures

    Pediatric patients treated conservatively for a fracture of a long bone, clavicle, patella, or sternum. During their standard scheduled outpatient follow-up visits, participants will undergo routine clinical evaluation and conventional radiography to monitor bone healing. Concurrently, a point-of-care ultrasound (POCUS) examination of the fracture site will be performed to calculate the Pediatric Long-bone Ultrasound Score (PLUS). The ultrasound assessment is strictly observational and does not alter standard medical care or clinical decision-making.

    Other: Point-of-care ultrasound

Interventions

  • OtherPoint-of-care ultrasound

    Additional ultrasound examination of the fracture site scored using the PLUS protocol, performed alongside standard clinical and radiographic follow-up. The ultrasound assessment is observational only and does not alter treatment decisions.

06

What researchers measure

Primary outcomes

  1. Diagnostic accuracy of the Pediatric Long-bone Ultrasound Score (PLUS) compared to conventional radiography

    The primary outcome is the diagnostic accuracy of the ultrasound-based PLUS (Pediatric Long-bone Ultrasound Score) in identifying fracture union, compared with the reference standard of clinical assessment and conventional radiography. Accuracy will be quantified using sensitivity, specificity, positive and negative predictive values, and receiver operating characteristic (ROC) analysis to determine the optimal PLUS cut-off for safely declaring union.

    Time frame: At the routine follow-up visit when fracture union is expected, usually 3 to 8 weeks after injury.

Secondary outcomes

  1. Inter-rater reliability of the PLUS ultrasound score

    The degree of agreement between the primary examining pediatric surgeon and an independent blinded reviewer in assigning the PLUS ultrasound score will be assessed. Reliability will be quantified using appropriate agreement statistics (e.g., Cohen's kappa and intraclass correlation), to determine whether the PLUS protocol is reproducible between different raters.

    Time frame: Assessed throughout the study period at the routine follow-up visit when fracture union is anticipated (typically 3 to 8 weeks post-injury).

  2. Influence of biological sex and pubertal stage on fracture healing dynamics

    The study will evaluate whether the temporal progression of sonographic fracture consolidation (PLUS score trajectories) differs according to biological sex and pubertal developmental stage. Time to union and PLUS score patterns will be compared between groups using appropriate survival and regression analyses, adjusting for age and fracture characteristics.

    Time frame: Assessed from injury until documented fracture union, typically within 3 to 8 weeks post-injury, depending on fracture type and patient age.

  3. Impact of ultrasound-based follow-up on outpatient workflow efficiency

    Outpatient visit duration and waiting times will be recorded and compared between the standard radiography-based pathway and a simulated ultrasound-centered pathway. The outcome will be the difference in total time spent in the outpatient clinic and the proportion of visits in which routine control X-rays could be safely avoided based on PLUS findings.

    Time frame: Assessed at each routine outpatient follow-up visit during the study period, typically within 3 to 8 weeks after injury.

  4. Association between maximum callus thickness and fracture union

    Maximum callus thickness measured on ultrasound will be explored as an auxiliary quantitative parameter and its relationship to clinical and radiographic fracture union will be assessed. This analysis is intended to determine whether a threshold value of callus thickness adds predictive value beyond the categorical PLUS score and whether it may refine interpretation of fracture healing.

    Time frame: Assessed at the routine follow-up visit when fracture union is anticipated, typically 3 to 8 weeks post-injury.

07

Study locations

1 site
  • University Hospital Hradec Kralove
    Hradec Králové, Czech Republic 50005, Czechia
    • Tomáš Merkl, M.D., Ph.D. · Contactmerkl.tomas5@gmail.com · +420724290230
    • Peter Kraus, M.D. · Contactpeter.kraus1@fnhk.cz · +420495833227
    • Tomáš Merkl, M.D., Ph.D. · Principal investigator
    • Peter Kraus, M.D. · Sub investigator
    • Zuzana Schröpfer, M.D. · Sub investigator
    • Radek Štichhauer, M.D., Ph.D. · Sub investigator
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because the study contains pediatric clinical data and imaging information collected for a single-center observational project. Data will be stored in secured institutional systems and will be analyzed within the study team. Any publication will use aggregated, de-identified results only. At this time, no external data-sharing plan has been approved.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Dec 2030, 51 months later.

Of 66 non-industry observational studies under Fractures, Bone, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 88. This study's planned 51 months is above that.

Counting every sponsor, half of 86 studies reached it within 46 months; a quarter within 20 and three quarters within 124.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 4, 2026
First posted
Aug 10, 2026
StartEst.
Sep 1, 2026
Primary completionEst.
Dec 31, 2030
CompletionEst.
Dec 31, 2030
Last update
Aug 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07755787
Lead sponsor
University Hospital Hradec Kralove
Collaborators
Masaryk University
Responsible party
Sponsor
First posted
Aug 10, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Dec 31, 2030 (estimated)
Completion
Dec 31, 2030 (estimated)
Last update
Aug 12, 2026

Study contacts

Tomáš Merkl, M.D., Ph.D.
Contact
tomas.merkl@fnhk.cz
+420724290230
Peter Kraus, M.D.
Contact
peter.kraus1@fnhk.cz
+420495833227
Tomáš Merkl, M.D., Ph.D.
principal investigator · University Hospital Hradec Králové

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion